A biosensor chip uses the sample solution as a measurement solvent to detect antigen concentrations directly.
Ferromagnetic nanoparticles embedded in photoresist allow magnetic probes to collect micropallets, bypassing slow inversion methods.
Muscle-derived stem cells from micro-biopsies assess drug efficacy and adverse effects, reducing development costs.
Segmented cell-based microarrays resolve low throughput bottlenecks by enabling parallel antigen identification via fluorogenic caspase activity.
Polymer stencils define patterned self-assembled monolayer arrays, reducing manual handling steps while controlling ligand identity and density.
Multi-wavelength illumination activates distinct fluorescent dye subsets to determine individual molecule positions with high spatial resolution.
Segmented microarray immobilization determines binding affinity using 500-fold less target protein than classical filter-based assays.
A three-channel fluorescence scanner measures sensitized emission to correct FRET distortion in two-color microarray experiments.
A cell microarray system identifies receptor ligand interactions using fluorescent protein tags and magnetic separation techniques.
Fluorescence-based detection replaces slow growth assays to resolve minor differences in pore-forming properties with minute-range temporal resolution.
Segment antibody variable domains to select stable pairs based on non-covalent interaction strength, overcoming slow traditional immunization methods.
Molecular dynamics simulations calculate residue metrics to identify correlated motions within biopolymer structures.
Optimized peptide selection overcomes poor ionization and adherence issues to achieve accurate protein quantitation in cancer diagnostics.
Unique molecular identifiers correct amplification biases during multiplex sequencing, ensuring accurate pairing of heavy and light chains.
Immortalized mammalian cell panels overcome limited primary cell lifespans to deliver reproducible in vitro models for compound toxicity assessment.